Recombinant Anti-AUH antibody [EPR11087(B)] - BSA and Azide free (ab215823)


  • Product name

    Anti-AUH antibody [EPR11087(B)] - BSA and Azide free
    See all AUH primary antibodies
  • Description

    Rabbit monoclonal [EPR11087(B)] to AUH - BSA and Azide free
  • Host species

  • Tested applications

    Suitable for: IHC-P, IP, WBmore details
    Unsuitable for: Flow Cyt or ICC/IF
  • Species reactivity

    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide within Human AUH. The exact sequence is proprietary. Corresponding to residues in Human AUH isoform 2.
    Database link: Q13825-2

  • Positive control

    • HepG2 and SH SY5Y cell lysates; Human fetal kidney lysate; Human pancreas tissue.
  • General notes

    Ab215823 is the carrier-free version of ab155980. This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.


    Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.

    Use our conjugation kits  for antibody conjugates that are ready-to-use in as little as 20 minutes with <1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

    ab215823 is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents.

    This product is a recombinant rabbit monoclonal antibody.



Our Abpromise guarantee covers the use of ab215823 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P Use at an assay dependent concentration. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
IP Use at an assay dependent concentration.
WB Use at an assay dependent concentration. Predicted molecular weight: 32 kDa.
  • Application notes
    Is unsuitable for Flow Cyt or ICC/IF.
  • Target

    • Relevance

      AUH (3-methylglutaconyl-CoA hydratase) catalyzes the conversion of 3-methylglutaconyl-CoA to 3-hydroxy-3-methylglutaryl-CoA and has very low enoyl-CoA hydratase activity. Deletion or mutation of the AUH gene causes the metabolic disease 3-methylglutaconic aciduria type I (MGA1). MGA type I is characterized by an abnormal organic acid profile in which there is excessive urinary excretion of 3-methylglutaconic acid, 3-methylglutaric acid and 3-hydroxyisovaleric acid. AUH is also an RNA-binding protein that binds in vitro to clustered 5'-AUUUA-3' motifs.
    • Cellular localization

    • Database links

    • Alternative names

      • 3 methylglutaconyl CoA hydratase antibody
      • AU binding protein/enoyl CoA hydratase antibody
      • AU RNA binding protein/enoyl CoA hydratase antibody
      • AU RNA binding protein/enoyl Coenzyme A hydratase antibody
      • AU specific RNA binding antibody
      • AU specific RNA binding enoyl CoA hydratase antibody
      • Methylglutaconyl CoA hydratase antibody
      • Methylglutaconyl CoA hydratase mitochondrial antibody
      • MGA Type I antibody
      see all


    ab215823 has not yet been referenced specifically in any publications.

    Customer reviews and Q&As

    There are currently no Customer reviews or Questions for ab215823.
    Please use the links above to contact us or submit feedback about this product.

    For licensing inquiries, please contact

    Sign up